Filing Details
- Accession Number:
- 0001683168-23-002405
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-14 16:20:05
- Reporting Period:
- 2023-04-12
- Accepted Time:
- 2023-04-14 16:20:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1729427 | Cns Pharmaceuticals Inc. | CNSP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1546797 | M John Climaco | C/O Cns Pharmaceuticals, Inc. 100 West Loop South, Suite 900 Houston TX 77027 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-04-12 | 15,000 | $0.69 | 45,010 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $0.677 to $0.70. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.